Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
pbi-shrna ews/fli1 type 1 lpx (1 trial)
pbi-shrna stmn1 lp (1 trial)
Neoplasm Metastasis (Phase 1)
Neoplasms (Phase 1)
Neoplasms, Second Primary (Phase 1)
Neuroectodermal Tumors, Primitive, Peripheral (Phase 1)
Rare Diseases (Phase 1)
Sarcoma (Phase 1)
Sarcoma, Ewing (Phase 1)
Trials (2 total)
Trial APIs (2 total)